Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
about
Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalenceAlternative dosage schedules with HPV virus-like particle vaccines.Prevention of cancer by prophylactic human papillomavirus vaccines.Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclassesHPV - immune response to infection and vaccinationRelationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® VaccineQuadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial.Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes.Clinical trials of human papillomavirus vaccines and beyond.Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study.
P2860
Q33924580-4B9F515F-C96C-4BC9-BF00-CE57195BB0AEQ34102466-9BB06975-07BA-4F63-A856-03E2EFE5E8F9Q34762053-072786DC-E52B-479E-890C-87A15729CB09Q34994905-741F104B-86ED-4778-BD76-3A643AE52242Q35180148-C8253A13-8FD4-4797-B387-C9B455EE3206Q35818648-202B4E16-612D-445A-AE50-A5AEDD55D0F9Q37279777-FE8766F2-C187-46D2-9FD3-93F29561A3A0Q37621787-79214228-6BCB-4CB4-A286-9DB328673326Q38111962-6FCAC63B-79B6-4AEF-806C-30CD683E4F63Q42260852-63894E8B-FEBD-4DD5-8AED-481FFC37305C
P2860
Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@ast
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@en
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@nl
type
label
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@ast
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@en
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@nl
prefLabel
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@ast
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@en
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@nl
P2093
P2860
P1433
P1476
Characterization of the HPV-sp ...... djuvanted HPV16 L1 VLP vaccine
@en
P2093
Clayton Harro
Joseph G Dauner
Ligia A Pinto
Yuanji Pan
P2860
P304
P356
10.1016/J.VACCINE.2010.06.018
P407
P577
2010-06-17T00:00:00Z